“Comparison of Efficacy and Safety of Vildagliptin and Linagliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease” (2025) Community Based Medical Journal, 14(1), pp. 96–100. doi:10.3329/cbmj.v14i1.79340.